Related Experiment Video
Updated: Jan 11, 2026
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
B-Type Natriuretic Peptides Levels in Patients With Beta-Thalassemia Major and Correlations With Biomarkers: A
Mohamed S K Salih1, Amna H Mohamed2, Elsara M A Mirghani2
1Harlem Hospital Center New York New York USA.
Background:
Patients with beta-thalassemia major are prone for developing cardiovascular complications. Early identification of patients at risk is important. B-type natriuretic peptides such as brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are sensitive indicators of cardiac dysfunction. This review synthesizes the existing evidence on the levels of B-type natriuretic peptides in beta-thalassemia major and their relationship with markers of cardiac dysfunction and other biomarkers.
Methods:
A systematic review was conducted according to PRISMA guidelines. The search was performed in the PubMed, Web of Science, ScienceDirect, and World Health Organization Virtual Health Library Regional Portal. Pooled standardized mean differences (SMD) and correlation coefficients (r) with 95% confidence intervals (CI) were calculated to investigate the differences in B-type natriuretic peptides values and their relationships with various biomarkers in beta-thalassemia major.
Results:
A total of 29 studies were selected for the systematic review. Of them, 27 were included in the meta-analyses. Most of the included studies focused on investigating NT-proBNP. The analyses revealed significantly higher NT-proBNP and BNP values in patients with beta-thalassemia major compared to healthy controls. For NT-proBNP, the pooled effect size (SMD) was 1.37 (95% CI: 0.856-1.893, p < 0.001), and for BNP, it was 1.94 (95% CI: 0.665-3.220, p = 0.003). Meta-analyses of correlations revealed that NT-proBNP was significantly correlated with serum ferritin levels (r = 0.471, p = 0.006), E/E' ratio (r = 0.528, p < 0.001), and patients age (r = 0.259, p = 0.004).
Conclusion:
This systematic review provides evidence that beta-thalassemia is associated with high levels of B-type natriuretic peptides, which highlight the high risk of cardiovascular complications in this patient population. The significantly elevated levels of both molecules and their identified correlations emphasize clinical utility of them as markers of early myocardial stress and subclinical heart disease in beta-thalassemia.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:17Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
01:29Heart Failure II: Pathophysiology
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies